CC(Oc1ccc2ccc(=O)oc2c1)C(=O)NC(Cc1c[nH]c2ccc(O)cc12)C(=O)O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?